These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 849258)

  • 61. Specifity of DNA-basic polypeptide interactions. Influence of neutral residues incorporated into polylysine and polyarginine.
    Wehling K; Arfmann HA; Standke KH; Wagner KG
    Nucleic Acids Res; 1975 Jun; 2(6):799-807. PubMed ID: 167352
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The mechanism of action of anticholinesterase drugs.
    BURGEN AS
    Br J Pharmacol Chemother; 1949 Sep; 4(3):219-28. PubMed ID: 18141083
    [No Abstract]   [Full Text] [Related]  

  • 63. Fluorometric system employing immobilized cholinesterase for assaying anticholinesterase compounds.
    Guilbault GG; Kramer DN
    Anal Chem; 1965 Dec; 37(13):1675-80. PubMed ID: 5846527
    [No Abstract]   [Full Text] [Related]  

  • 64. Increased extracellular production of a cholinesterase-solubilising factor by Cytophaga NCMB 1314 during magnesium starvation.
    Bovallius A
    Can J Microbiol; 1978 Apr; 24(4):381-5. PubMed ID: 638892
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interaction of basic polyamino acids with the red blood cell. I. Combination of polylysine with single cells.
    NEVO A; DE VRIES A; KATCHALSKY A
    Biochim Biophys Acta; 1955 Aug; 17(4):536-47. PubMed ID: 13250001
    [No Abstract]   [Full Text] [Related]  

  • 66. The chromatography of polylysine.
    STEWART JW; STAHMANN MA
    J Chromatogr; 1962 Oct; 9():233-5. PubMed ID: 13984108
    [No Abstract]   [Full Text] [Related]  

  • 67. The Effects of Anticholinesterase Agents on the Blood Cholinesterases Levels of Normal and Glaucoma Subjects.
    Leopold IH; Krishna N; Lehman RA
    Trans Am Ophthalmol Soc; 1959; 57():63-86. PubMed ID: 16693589
    [No Abstract]   [Full Text] [Related]  

  • 68. Are interactions with phospholipids responsible for pharmacological activities of cardiotoxins?
    Bougis P; Tessier M; Van Rietschoten J; Rochat H; Faucon JF; Dufourcq J
    Mol Cell Biochem; 1983; 55(1):49-64. PubMed ID: 6353198
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antineoplastic activity of poly(L-lysine) with some ascites tumor cells.
    Arnold LJ; Dagan A; Gutheil J; Kaplan NO
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3246-50. PubMed ID: 291000
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ["Substrate inhibition"--one of the aspects of substrate specificity of cholinesterases in vertebrates and invertebrates].
    Moralev SN; Rozengart EV
    Zh Evol Biokhim Fiziol; 2001; 37(5):358-73. PubMed ID: 11771237
    [No Abstract]   [Full Text] [Related]  

  • 71. Mechanism of anticholinesterase activities of cardiotoxin, protamine and polylysine.
    Lin SY; Liao C; Lee CY
    Biochem J; 1977 Feb; 161(2):229-32. PubMed ID: 849258
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Further studies on mechanism of anticholinesterase activities of cardiotoxin, protamine and polylysine.
    Shiau SY; Liao C; Lee CY
    Taiwan Yi Xue Hui Za Zhi; 1976 Dec; 75(12):693-9. PubMed ID: 1071758
    [No Abstract]   [Full Text] [Related]  

  • 73. Studies on anti-cholinesterase activity of cobra cardiotoxin.
    Shiau Lin SY; Liao C; Lee CY
    Taiwan Yi Xue Hui Za Zhi; 1976 Aug; 75(8):440-8. PubMed ID: 10341
    [No Abstract]   [Full Text] [Related]  

  • 74. Polyarginine, polylysine, and protamine mimic the effects of high extracellular calcium concentrations on dispersed bovine parathyroid cells.
    Brown EM; Katz C; Butters R; Kifor O
    J Bone Miner Res; 1991 Nov; 6(11):1217-25. PubMed ID: 1666808
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Binding of isolated rheumatoid factors to histone proteins and basic polycations.
    Hobbs RN; Lea DJ; Phua KK; Johnson PM
    Ann Rheum Dis; 1983 Aug; 42(4):435-8. PubMed ID: 6349552
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differentiation of 3 types of competitive cholinesterase inhibitors.
    MYERS DK
    Arch Biochem Biophys; 1951 Mar; 31(1):29-40. PubMed ID: 14820335
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.